Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Ncgc00018263-02
2. Chembl67128
3. Chebi:181452
4. Akos015917554
Molecular Weight | 446.6 g/mol |
---|---|
Molecular Formula | C26H38O6 |
XLogP3 | 3.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 446.26683893 g/mol |
Monoisotopic Mass | 446.26683893 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 832 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 6 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Hydrocortisone valerate |
PubMed Health | Hydrocortisone Valerate (Topical application route) |
Drug Classes | Corticosteroid, Intermediate, Hydrocortisone |
Active Ingredient | Hydrocortisone valerate |
Dosage Form | Ointment; Cream |
Route | Topical |
Strength | 0.2% |
Market Status | Prescription |
Company | Taro; Perrigo New York |
2 of 2 | |
---|---|
Drug Name | Hydrocortisone valerate |
PubMed Health | Hydrocortisone Valerate (Topical application route) |
Drug Classes | Corticosteroid, Intermediate, Hydrocortisone |
Active Ingredient | Hydrocortisone valerate |
Dosage Form | Ointment; Cream |
Route | Topical |
Strength | 0.2% |
Market Status | Prescription |
Company | Taro; Perrigo New York |
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?